Type of security: Stock
Sector: Health Care
Industry: Precision Instruments
The data is delayed by 15 minutes.
Description: NeoGenomics, Inc., together with its subsidiary, NeoGenomics Laboratories, Inc., operates a network of cancer-focused testing laboratories providing genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, and other laboratories in the United States. The company performs analyses for hematopoietic cancers, such as leukemia and lymphoma; and solid tumor cancers comprising breast, lung, colon, and bladder cancer. It offers cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; immunohistochemistry testing services to identify cell proteins in a tissue section; and molecular testing services that focus on the analysis of DNA and RNA, as well as on t
|Shares Outstanding||EPS||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||Sales Growth - 4 Quarters||11.4%||Sales Growth - Q/Q||-7.89%||P/E|
|P/E To EPS Growth||P/S||P/BV||Price/Cash Per Share|
|Price/Free Cash Flow||ROA||0.33%||ROE||0.45%||ROI|
|Current Ratio||4.14||Quick Ratio||3.95||Long Term Debt/Equity||0.15||Debt Ratio||0.23|
|Gross Margin||45.2%||Operating Margin||1.37%||Net Profit Margin||0.29%||Dividend Payout Ratio|
|Cash From Financing Activities||-1.45 M||Cash From Investing Activities||-1.18 M||Cash From Operating Activities||1.9 M||Gross Profit||10.81 M|
|Net Profit||-180 K||Operating Profit||30 K||Total Assets||82.97 M||Total Current Assets||59.6 M|
|Total Current Liabilities||15.12 M||Total Debt||10.05 M||Total Liabilities||22.1 M||Total Revenue||24.37 M|
|High 52 week||18.5||Low 52 week||7.23||Last close||15.3||Last change||0.46%|
|RSI||83.07||Average true range||0.64||Beta||0.33||Volume||150.71 K|
|Simple moving average 20 days||16.73%||Simple moving average 50 days||3.81%||Simple moving average 200 days||15.02%|
|Performance Week||2.2%||Performance Month||15.47%||Performance Quart||13.42%||Performance Half||9.6%|
|Performance Year||91.97%||Performance Year-to-date||21.33%||Volatility daily||3.93%||Volatility weekly||8.8%|
|Volatility monthly||18.02%||Volatility yearly||62.44%||Relative Volume||210.71%||Average Volume||1.45 M|
|New High||New Low|
2019-06-23 15:51:41 | Did Hedge Funds Drop The Ball On NeoGenomics, Inc. NEO ?
2019-06-13 08:06:18 | See what the IHS Markit Score report has to say about Neogenomics Inc.
2019-06-10 08:04:52 | See what the IHS Markit Score report has to say about Neogenomics Inc.
2019-06-06 08:06:21 | See what the IHS Markit Score report has to say about Neogenomics Inc.
2019-06-04 08:02:35 | See what the IHS Markit Score report has to say about Neogenomics Inc.
2019-05-30 16:05:00 | NeoGenomics To Present At 39th Annual William Blair Growth Stock Conference
2019-05-23 16:30:00 | NeoGenomics To Attend The 16th Annual Craig-Hallum Institutional Investor Conference
2019-05-21 20:10:00 | NeoGenomics Announces Pricing on Public Offering of Common Stock
2019-05-21 09:03:13 | See what the IHS Markit Score report has to say about Neogenomics Inc.
2019-05-21 07:36:11 | Dow Jones Futures Signal Stock Market Rally As China Trade War Tensions Ease
2019-05-21 00:14:11 | Dow Jones Futures: Stock Market Rally Hit Again As China Trade War Slams Chip Stocks
2019-05-20 16:12:00 | NeoGenomics Announces Proposed Public Offering of Common Stock
2019-05-07 12:16:06 | Are NeoGenomics, Inc.'s NASDAQ:NEO Interest Costs Too High?
2019-05-03 09:15:01 | NeoGenomics NEO Hits Fresh High: Is There Still Room to Run?
2019-05-02 14:40:13 | Hedge Funds Have Never Been This Bullish On NeoGenomics, Inc. NEO
2019-04-30 15:17:24 | Edited Transcript of NEO earnings conference call or presentation 30-Apr-19 12:30pm GMT
2019-04-30 14:03:30 | Neogenomics Inc NEO Q1 2019 Earnings Call Transcript
2019-04-30 09:35:01 | NeoGenomics NEO Tops Q1 Earnings and Revenue Estimates
2019-04-30 08:27:23 | NeoGenomics: 1Q Earnings Snapshot
2019-04-30 07:00:00 | NeoGenomics Reports 51% Revenue Growth to Record $96 Million in the First Quarter
2019-04-23 10:32:02 | NeoGenomics NEO Earnings Expected to Grow: What to Know Ahead of Next Week's Release
2019-04-03 16:35:00 | NeoGenomics Schedules its First Quarter Earnings Release for April 30, 2019
2019-04-02 17:20:00 | NeoGenomics to Present at 18th Annual Needham & Company Health Care Conference
2019-04-02 11:54:53 | See what the IHS Markit Score report has to say about Neogenomics Inc.
2019-03-28 07:20:00 | Report: Developing Opportunities within Carter's, Ingredion, NeoGenomics, American Financial Group, Inogen, and Forrester Research — Future Expectations, Projections Moving into 2019
2019-03-26 08:25:03 | See what the IHS Markit Score report has to say about Neogenomics Inc.
2019-03-12 10:27:28 | See what the IHS Markit Score report has to say about Neogenomics Inc.
2019-03-11 12:59:00 | Here's Why Genetic Testing Stocks Rose as Much as 42.9% in February
2019-03-07 16:50:00 | NeoGenomics To Present At 39th Annual Cowen and Company Health Care Conference
2019-03-05 08:06:29 | See what the IHS Markit Score report has to say about Neogenomics Inc.
2019-02-23 19:09:29 | Back Above $4k: Bitcoin’s Price Jumps to a Two-Month High
2019-02-20 00:40:04 | Edited Transcript of NEO earnings conference call or presentation 19-Feb-19 1:30pm GMT
2019-02-19 14:22:50 | Neogenomics Inc NEO Q4 2018 Earnings Conference Call Transcript
2019-02-19 07:32:41 | NeoGenomics: 4Q Earnings Snapshot
2019-02-19 06:30:00 | NeoGenomics, Inc. to Host Earnings Call
2019-02-12 15:00:12 | Is NeoGenomics, Inc. NASDAQ:NEO Excessively Paying Its CEO?
2019-02-12 10:30:03 | NeoGenomics NEO Reports Next Week: What to Know Ahead of the Release
2019-02-12 08:19:01 | 5 Breakout Stocks for Stellar Returns
2019-02-08 22:33:00 | Here's Why Genetic Testing Stocks Rose as Much as 31.8% in January
2019-02-08 08:03:12 | See what the IHS Markit Score report has to say about Neogenomics Inc.
2019-01-29 13:10:00 | NeoGenomics Is Poised For Further Gains - Go Long on a Shallow Dip
2019-01-29 09:30:02 | Is NeoGenomics NEO Outperforming Other Medical Stocks This Year?
2019-01-24 08:07:01 | See what the IHS Markit Score report has to say about Neogenomics Inc.
2019-01-22 19:11:00 | 3 Top Growth Stocks to Buy Right Now
2019-01-18 07:40:00 | Report: Developing Opportunities within Macerich, Illinois Tool Works, NeoGenomics, Bunge, Dolby Laboratories, and Cracker Barrel Old Country Store — Future Expectations, Projections Moving into 2019